Search results
Showing 2116 to 2130 of 2172 results for technology appraisal
Support for delivering quality, safety and efficiency in the optimisation of medicines.
We work with the clinical classifications service of NHS Digital to provide relevant clinical coding information for interventional procedure and medical technologies guidance.
Tell us about an interventional procedure you think should be assessed by NICE.
Home What NICE does Our guidance About technology appraisal guidance...
Summaries of the best available evidence for selected medicines that are considered to be of significance to the NHS.
We’re bringing our guidance together by topic, so that it’s all in one place, clearer to understand and easier to use.
Learn more about what NICE content is available for reuse by checking our information asset register.
These are the main stages in the multiple technology appraisal process used before April 2018.
Cutting-edge robotic surgery gets green light as 11 systems are recommended
Eleven cutting-edge robotic surgery systems have been approved for use, potentially transforming care for thousands of NHS patients undergoing soft tissue and orthopaedic procedures.
Record number of positive recommendations for blood cancer treatments
Around 5,000 blood cancer patients could benefit from 13 treatments recommended by NICE in 2024.
HST routing criteria: encouraging innovation in the treatment of ultra-rare diseases
Our chief medical officer, Professor Jonathan Benger, explains the crucial role the HST programme plays in encouraging innovation in the treatment of ultra-rare diseases. He also highlights why effective routing is essential to getting the best care to patients across the NHS.
NICE approves groundbreaking one-off gene therapy for severe sickle cell disease
People in England with severe sickle cell disease will be among the first to receive treatment using revolutionary CRISPR gene editing technology, following publication of our final draft guidance today.
5 ways NICE Advice can help you navigate this new opportunity alongside health technology assessment.
Consultation on changes to technology appraisals and highly specialised technologies
What NICE does Our guidance About technology appraisal guidance Our methods and processes (health technology evaluation...
NICE chronic lung disease treatment decision could benefit 5,200 people
NICE broadens nintedanib recommendation on chronic lung disease treatment.